ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease
Gastroesophageal reflux disease (GERD) continues to be among the most common
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
diseases seen by gastroenterologists, surgeons, and primary care physicians. Our …
Contribution of the intestinal microbiome and gut barrier to hepatic disorders
DM Chopyk, A Grakoui - Gastroenterology, 2020 - Elsevier
Intestinal barrier dysfunction and dysbiosis contribute to development of diseases in liver
and other organs. Physical, immunologic, and microbiologic (bacterial, fungal, archaeal …
and other organs. Physical, immunologic, and microbiologic (bacterial, fungal, archaeal …
Increased risk of COVID-19 among users of proton pump inhibitors
CV Almario, WD Chey… - Official journal of the …, 2020 - journals.lww.com
METHODS: From May 3 to June 24, 2020, we performed an online survey described to
participating adults as a “national health survey.” A multivariable logistic regression was …
participating adults as a “national health survey.” A multivariable logistic regression was …
The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association
DE Freedberg, LS Kim, YX Yang - Gastroenterology, 2017 - Elsevier
Background & Aims The purpose of this review is to evaluate the risks associated with long-
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
term use of proton pump inhibitors (PPIs), focusing on long-term use of PPIs for three …
25 years of proton pump inhibitors: a comprehensive review
DS Strand, D Kim, DA Peura - Gut and liver, 2016 - pmc.ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) were clinically introduced more than 25 years ago and have
since proven to be invaluable, safe, and effective agents for the management of a variety of …
since proven to be invaluable, safe, and effective agents for the management of a variety of …
Complications of proton pump inhibitor therapy
Safety issues associated with proton pump inhibitors (PPIs) have recently attracted
widespread media and lay attention. Gastroenterologists are frequently asked about the …
widespread media and lay attention. Gastroenterologists are frequently asked about the …
Small intestinal bacterial overgrowth—pathophysiology and its implications for definition and management
D Bushyhead, EMM Quigley - Gastroenterology, 2022 - Elsevier
The concept of small intestinal bacterial overgrowth (SIBO) arose in the context of
maldigestion and malabsorption among patients with obvious risk factors that permitted the …
maldigestion and malabsorption among patients with obvious risk factors that permitted the …
Effective and safe proton pump inhibitor therapy in acid-related diseases–a position paper addressing benefits and potential harms of acid suppression
Background The introduction of proton pump inhibitors (PPIs) into clinical practice has
revolutionized the management of acid-related diseases. Studies in primary care and …
revolutionized the management of acid-related diseases. Studies in primary care and …
Proton-pump inhibitors: understanding the complications and risks
P Malfertheiner, A Kandulski, M Venerito - … Reviews Gastroenterology & …, 2017 - nature.com
Proton-pump inhibitors (PPIs) are the most effective therapy for the full spectrum of gastric-
acid-related diseases. However, in the past decade, a steadily increasing list of …
acid-related diseases. However, in the past decade, a steadily increasing list of …
[HTML][HTML] Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
G Bruno, P Zaccari, G Rocco, G Scalese… - World journal of …, 2019 - ncbi.nlm.nih.gov
Proton pump inhibitors (PPIs) are common medications within the practice of
gastroenterology. These drugs, which act through the irreversible inhibition of the …
gastroenterology. These drugs, which act through the irreversible inhibition of the …